EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mitochondria regulate MR1 protein expression and produce self-metabolites that activate MR1-restricted T cells

Gennaro Prota iD, Giuliano Berloffa iD, Wael Awad iD, Alessandro Vacchini iD, Andrew Chancellor, Verena Schaefer iD, Daniel Constantin, Dene R Littler iD, Rodrigo Colombo, Vladimir Nosi, Lucia Mori, Jamie Rossjohn iD und 1 weitere

Proceedings of the National Academy of Sciences · 20.05.2025 · 122 (20)

DOI: 10.1073/pnas.2418525122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 12.05.2025. Verfasst von Gennaro Prota und 12 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel, Basel 4031, Switzerland. Hauptthemen laut MEDLINE: Mitochondria, T-Lymphocytes, Histocompatibility Antigens Class I, Minor Histocompatibility Antigens. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Australian Cancer Research Foundation (ACRF), Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF), Krebsliga Beider Basel (Cancer League of Basel-City and Basel-Country).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria coordinate several metabolic pathways, producing metabolites that influence the immune response in various ways. It remains unclear whether mitochondria impact antigen presentation by the MHC-class-I-related antigen-presenting molecule, MR1, which presents small molecules to MR1-restricted T-lymphocytes. Here, we demonstrate that mitochondrial complex III and the enzyme dihydroorotate dehydrogenase are essential for the cell-surface expression of MR1 and for generating uridine- and thymidine-related compounds that bind to MR1 and are produced upon oxidation by reactive oxygen species. One mitochondria-derived immunogenic formylated metabolite we identified is 5-formyl-deoxyuridine (5-FdU). Structural studies indicate that 5-FdU binds in the A’-antigen-binding pocket of MR1, positioning the deoxyribose toward the surface of MR1 for TCR interaction. 5-FdU stimulates specific T cells and detects circulating T cells when loaded onto MR1-tetramers. 5-FdU-reactive cells resemble adaptive T cells and express the phenotypes of naïve, memory, and effector cells, indicating prior in vivo stimulation. These findings suggest that mitochondria may play a role in MR1-mediated immune surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaT-LymphocytesHistocompatibility Antigens Class IMinor Histocompatibility AntigensAnimalsHumansMiceDihydroorotate DehydrogenaseOxidoreductases Acting on CH-CH Group DonorsLymphocyte ActivationAntigen PresentationReactive Oxygen SpeciesMice, Inbred C57BL

Stichwörter der Autor:innen

MR1T cellsantigen presentationformylated metabolitemitochondria

Substanzen

Histocompatibility Antigens Class IMinor Histocompatibility AntigensMR1 protein, humanDihydroorotate DehydrogenaseOxidoreductases Acting on CH-CH Group DonorsReactive Oxygen Species

Autor:innen und Institutionen

  • Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel, Basel 4031, Switzerland.
  • Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
  • Institute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4YS, United Kingdom.

ORCID-Profile: Gennaro Prota, Giuliano Berloffa, Wael Awad, Alessandro Vacchini, Verena Schaefer, Dene R Littler, Jamie Rossjohn, Gennaro De Libero

Förderung

  • Australian Cancer Research Foundation (ACRF)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF)
  • Krebsliga Beider Basel (Cancer League of Basel-City and Basel-Country)
  • HHS | NIH (NIH)
  • Swiss Cancer Research Foundation (Swiss Cancer Research)
  • NIAID NIH HHS

Zitieren

APA

Prota, G., Berloffa, G., Awad, W., Vacchini, A., Chancellor, A., Schaefer, V., Constantin, D., Littler, D. R., Colombo, R., Nosi, V., Mori, L., Rossjohn, J., & De Libero, G. (2025). Mitochondria regulate MR1 protein expression and produce self-metabolites that activate MR1-restricted T cells. Proceedings of the National Academy of Sciences, 122(20). https://doi.org/10.1073/pnas.2418525122

Vancouver

Prota G, Berloffa G, Awad W, Vacchini A, Chancellor A, Schaefer V, et al. Mitochondria regulate MR1 protein expression and produce self-metabolites that activate MR1-restricted T cells. Proceedings of the National Academy of Sciences. 2025;122(20). doi:10.1073/pnas.2418525122

BibTeX
@article{Prota2025,
  author = {Prota, Gennaro and Berloffa, Giuliano and Awad, Wael and Vacchini, Alessandro and Chancellor, Andrew and Schaefer, Verena and Constantin, Daniel and Littler, Dene R and Colombo, Rodrigo and Nosi, Vladimir and Mori, Lucia and Rossjohn, Jamie and De Libero, Gennaro},
  title = {Mitochondria regulate MR1 protein expression and produce self-metabolites that activate MR1-restricted T cells},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {20},
  doi = {10.1073/pnas.2418525122}
}
Kostenlos starten →